Metraipolis › archive › dc_277d932872ea

Efficacy and tolerability of rituximab in patients with pemphigus foliaceus: a single-centre retrospective cohort study — Europe PMC PMID:42539993

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42539993
DOI
10.1093/skinhd/vzag025
License (as archived)
solo-consultazione
Archived
2026-11-03T00:00:37.457Z
SHA-256 of the archived text
feb7dcb0ad387ebab7ad1198b10addf036f28df509d6c1ceee5402747cc97b9d
Stable URL of this page
https://metraipolis.com/documento/dc_277d932872ea

How to cite

Efficacy and tolerability of rituximab in patients with pemphigus foliaceus: a single-centre retrospective cohort study — Europe PMC PMID:42539993 — Europe PMC (en), https://europepmc.org/article/MED/42539993 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_277d932872ea (Metraipolis archive dc_277d932872ea, sha256 feb7dcb0ad387ebab7ad1198b10addf036f28df509d6c1ceee5402747cc97b9d)
BibTeX
@misc{dc277d932872ea,
  title = {Efficacy and tolerability of rituximab in patients with pemphigus foliaceus: a single-centre retrospective cohort study — Europe PMC PMID:42539993},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42539993},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_277d932872ea; sha256 feb7dcb0ad387ebab7ad1198b10addf036f28df509d6c1ceee5402747cc97b9d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42539993. Agents can read the archived copy with the MCP tool read_document.